NCT01555957View on ClinicalTrials.gov

Prospective Randomized Clinical Trial of Intravenous Lipids and Cholestasis

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

October 30, 2018

Study Completion Date

January 31, 2019

Conditions
Parenteral Nutrition Associated Cholestasis
Interventions
DRUG

intravenous lipid

intravenous given daily for 6 weeks

Trial Locations (1)

14642

University of Rochester, Rochester

All Listed Sponsors
lead

University of Rochester

OTHER

NCT01555957 - Prospective Randomized Clinical Trial of Intravenous Lipids and Cholestasis | Biotech Hunter | Biotech Hunter